MarketInOut Stock Screener Log In | Sign Up

BLS Pharmaceuticals Ltd

Healthcare • Biotechnology • Quote as of 10/29/2026 16:10
BLS Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization215.95 mln
Float63.67 mln
Earnings Date02/25/2027

EPS

0.07
Marginal

P / E

14.79
Fair value

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-0.51
Highly suspicious

Relative Strength

32 / 100
Underperforming

Debt / Equity

0.27
Very low leverage

Business Description

BLS Pharmaceuticals Limited is a Sydney-based company that manufactures and distributes a range of medicines and health products across Australia, the United Kingdom, Europe, and Japan. Its portfolio spans prescription and controlled substances including cannabis, psilocybin, and MDMA, alongside consumer health goods sold under the Dr Watson brand and probiotic products targeting gut health and immunity. The company also offers contract manufacturing, storage, and distribution services to third parties.

Key Fundamentals

EPS0.07
P/E14.79
ROE72.55
RPS0.33
ROIC81.42
ROA43.46
Interest Cover34.36
EBITDA, mln17.00
EV / EBITDA13.22
EV / EBIT14.40
Revenue, mln74.17
EV / Revenue3.03

Quote Details

Last 1.05
Change 0.04 (3.96%)
Open 1.02
Volume 166,067
Turnover 174,370
Average Volume 262,761

Financial Ratios

Pre-Tax Profit Margin20
Current Ratio2.90
Price / Book7.78
Price / Tangible Book7.65
Price / Free Cash Flow150
Debt / Equity0.27
Price / Sales3.26
PEG Ratio2.67

Financial Strength

Altman Z-Score9.71
Piotroski F-Score 5 / 9
Beneish M-Score-0.51
Price to Intrinsic Value9.05
Price to Graham Number2.21

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 13.51% 95 / 100   
1 Month 0% 66 / 100   
2 Months 28.83% 94 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog